Tsutomu Takahashi

ORCID: 0000-0003-2838-319X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Kawasaki Disease and Coronary Complications
  • Coronary Artery Anomalies
  • Neonatal Respiratory Health Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Arrest and Resuscitation
  • Pharmaceutical Economics and Policy
  • Congenital Diaphragmatic Hernia Studies
  • Lipoproteins and Cardiovascular Health
  • Streptococcal Infections and Treatments
  • Cardiovascular Effects of Exercise
  • Cardiovascular Issues in Pregnancy
  • Injury Epidemiology and Prevention
  • Mitochondrial Function and Pathology
  • Mechanical Circulatory Support Devices
  • Hip disorders and treatments
  • Hedgehog Signaling Pathway Studies
  • Neurosurgical Procedures and Complications
  • Fibroblast Growth Factor Research
  • Pharmacological Effects of Natural Compounds
  • Intestinal Malrotation and Obstruction Disorders
  • Anesthesia and Pain Management
  • Pharmacy and Medical Practices
  • Superconducting Materials and Applications
  • ATP Synthase and ATPases Research
  • Soft tissue tumor case studies

Saiseikai Utsunomiya hospital
2013-2025

Hoshigaoka Medical Center
2025

Japan Community Healthcare Organization
2025

Akita University
2021-2025

Pediatrics and Genetics
2011

Nihon University
2001-2009

Surugadai Nihon University Hospital
2008

Kagawa University
2004-2005

Few studies with sufficient statistical power have shown the association of z score coronary arterial internal diameter events (CE) in patients Kawasaki disease (KD) artery aneurysms (CAA).To clarify time-dependent CE occurrence KD CAA.This multicenter, collaborative retrospective cohort study 44 participating institutions included 1006 younger than 19 years who received a angiography between 1992 and 2011.The CE, including thrombosis, stenosis, obstruction, acute ischemic events,...

10.1001/jamapediatrics.2018.0030 article EN JAMA Pediatrics 2018-03-05

After focal cerebral ischemia, tumor necrosis factor-alpha deteriorates edema and survival rate. Therefore, neutralization could reduce microvascular permeability in acute ischemia. Left middle artery occlusion for 120 mins followed by reperfusion was performed with the thread method under halothane anesthesia Sprague-Dawley rats. Antirat neutralizing monoclonal antibody a rat IgG Fc portion (15 mg/kg) infused intravenously right after reperfusion. Stroke index score, infarct volume,...

10.1038/sj.jcbfm.9600086 article EN Journal of Cerebral Blood Flow & Metabolism 2005-02-23

Background Coronary arterial aneurysms (CAAs) associated with Kawasaki disease (KD) significantly affect prognosis. However, the clinical course of CAAs and factors CAA regression have not been well analyzed. Methods Results The cohort Z-Score 2nd Project Stage study, a multicenter, retrospective, study involving 44 institutions in Japan including 1006 patients KD, was examined. were classified by z score their internal diameter acute phase: small (z<5), medium (5≤z<10), large (z≥10). lower...

10.1161/jaha.121.022417 article EN cc-by-nc-nd Journal of the American Heart Association 2023-01-31

Background: Circumstances and outcomes of out-of-hospital cardiac arrest (OHCA) in elementary middle school students while at the era public-access defibrillation are unknown. Methods Results: We conducted a nationwide hospital-based survey who had OHCA origin received prehospital resuscitation 2005–2009. Among 58 cases recruited, 90% were witnessed by bystanders; 86% ventricular fibrillation as initial rhythm; 74% resuscitated 24% defibrillated 55% occurred school; 66% exercise-related; 48%...

10.1253/circj.cj-13-1162 article EN Circulation Journal 2014-01-01

Abstract Familial adenomatous polyposis (FAP) is an inherited disorder that follows autosomal dominant inheritance pattern and caused by a germline pathogenic variant in the APC gene. FAP also has extracolonic manifestations, including osteomas, brain tumors, congenital hypertrophy of retinal pigmented epithelium. Desmoid tumor rare soft-tissue often associated with FAP. WNT signal transduction molecule abundantly expressed central nervous system. The truncation mutations gene are...

10.1093/jjco/hyae181 article EN Japanese Journal of Clinical Oncology 2025-01-05

Abstract Background Stroke is a leading cause of death, reducing disability-free life expectancy. After acute treatment, patients require rehabilitation to prevent recurrence. Continued use medication crucial for recurrence prevention and risk management, even after the transition from acute-care institutions other medical institutions. Although “discharge summaries on medications” are shared between hospitals community pharmacists, no reports have addressed continuity with stroke...

10.1186/s40780-025-00415-8 article EN cc-by Journal of Pharmaceutical Health Care and Sciences 2025-02-03

Objective Cytochrome c oxidase (COX) deficiency is a major mitochondrial respiratory chain defect that has vast genetic and phenotypic heterogeneity. This study aims to identify novel causative genes of COX with only striated muscle–specific symptoms. Methods Whole exome sequencing was performed in 2 unrelated individuals who were diagnosed congenital myopathy presented muscle pathology. We assessed the COX6A2 variants using measurements enzymatic activities assembly complexes samples from...

10.1002/ana.25517 article EN Annals of Neurology 2019-06-03

The overexpression of imprinted genes on chromosome 6q24 causes 6q24-related transient neonatal diabetes mellitus (6q24-TNDM). Most cases 6q24-TNDM show (DM) during the period, followed by relapse after puberty. These two courses DM are both characterized insulin insufficiency. However, there has been no previously reported case with resistance at relapse. We report a 10-yr-old Japanese girl relapsing 6q24-TNDM. In she had hyperglycemia and was treated injection until 2 mo age. After several...

10.1297/cpe.29.179 article EN Clinical Pediatric Endocrinology 2020-01-01
Gunnel Carlsson Anders Möller Christian Blomstrand Takashi Ueda Katsufumi Mizushige and 95 more Kazushi Yukiiri Tsutomu Takahashi Masakazu Kohno Terry B.J. Kuo Chang-Ming Chern Cheryl C.H. Yang Hung-Yi Hsu Wen-Jang Wong Wen-Yung Sheng Han‐Hwa Hu Antonio Di Carlo Domenico Inzitari Franco Galati Marzia Baldereschi Vincenzo Giunta Gaetano Grillo Alfonso Furchì Valerio Manno Francesco Naso A. Del Vecchio Domenico Consoli Yong Hoon Jeong Gyeong‐Moon Kim Young Min Song Duk L. Na Alexandra Montavont N. Nighoghossian M. Hermier Laurent Derex Y. Berthezène E. Philippeau Jérôme Honnorat J.C. Froment Louis R. Caplan P. Trouillas Biodun Ogungbo Barbara Gregson A. David Mendelow Erwin Stolz Christof Klötzsch Anousha Rahimi Felix Schlachetzki Manfred Kaps Louise Martinsson Staffan Eksborg Nils Wahlgren José M. Ferro Andrea Steck Dietmar Krex Andreas Ziegler Inke R. König Hans K. Schackert Gabriele Schackert Karin Rossnagel Jacqueline Müller‐Nordhorn Michael Kulig Stefan N. Willich Aude Triquenot-Bagan Emmanuel Gérardin E. Guégan-Massardier Y. Onnient Fleur Leroy B Mihout Jonas Weber Eberhard Kirsch Ernst-Wilhelm Radü Hermann Kaiser Ph.A. Lyrer Shuzo Shintani Shin Tsuruoka Tatsuo Shiigai Kenji Ishii Adrià Arboix Montserrat Oliveres Luis García‐Eroles Emili Comes Miquel Balcells Cecília Targa Jae‐Kwan Cha Min‐Ho Jeong Jiyeon Jang Hae-Rahn Bae Yeong-Jin Lim Jung Sun Kim Sang-Ho Kim Jae Woo Kim Ynte M. Ruigrok Ale Algra Gabriël J.E. Rinkel David Quartermain Yong Sheng Li Saran Jonas Eduardo Martínez-Vila José A. Páramo Óscar Beloqui

10.1159/000073534 article CA Cerebrovascular Diseases 2003-01-01

Flat-sum payment systems for treatment costs, such as the Diagnosis Procedure Combination (DPC) system, are now being introduced in medical institutions. Owing to introduction of systems, hospital pharmacists required be more actively involved selection drugs through provision appropriate drug information including that on cost effectiveness. In Japan, however, very few pharmacoeconomic evaluations by have been reported date. view this, we conducted a evaluation HMG-CoA reductase inhibitors...

10.5649/jjphcs.32.320 article EN Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2006-01-01

It has been demonstrated that HMG-CoA reductase inhibitors effectively decrease low density lipoprotein and total cholesterol levels, presently, are most widely used in hyperlipidemia treatment. On the other hand, it fibrate agents triglyceride levels more compared to inhibitors. A cost-effectiveness study comparing fenofibrate, a agent, atorvastatin was therefore conducted hypertriglyceridemia patients. Referring an analytical method published UK, percentage of patients received fenofibrate...

10.1248/yakushi.128.1783 article EN YAKUGAKU ZASSHI 2008-12-01
Coming Soon ...